Companies › CPRX
CATALYST PHARMACEUTICALS INC (CPRX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001369568 · EDGAR filings · Updated 2026-07-24
CATALYST PHARMACEUTICALS INC (CPRX) has reported institutional ownership of 85.2%, with 379 institutional managers holding positions valued at $2.58B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).
Filings this week (1)
- 2026-07-24 — 15-12G filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-17 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CATALYST PHARMACEUTICALS INC has 379 institutional holders and institutional ownership of 85.2%.
Insider activity
Insiders reported 80 transactions (0 buys, 18 sells) across 15 reporting insiders, with a net reported value of −$19.6M.
Data flags from SEC filings
Related companies
DISC MEDICINE INC (IRON) · HAEMONETICS CORP MASS (HAE) · 10X GENOMICS INC (TXG) · BEAM THERAPEUTICS INC (BEAM) · ARCUS BIOSCIENCES INC COM (RCUS) · ORUKA THERAPEUTICS INC (ORKA)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.